Heart Failure Clinics

Papers
(The median citation count of Heart Failure Clinics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Hypertrophic Cardiomyopathy in RASopathies40
Exercise-Based Cardiac Rehabilitation Programs in Heart Failure Patients33
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease22
Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction21
Clinical Manifestations of 22q11.2 Deletion Syndrome21
Advanced Heart Failure21
Left Ventricular Assist Device20
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction20
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy19
Pathophysiology of Heart Failure with Preserved Ejection Fraction19
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure18
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis18
Cardiovascular Involvement in mtDNA Disease18
The Risk of Sudden Unexpected Cardiac Death in Children16
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia16
Inotropes in Patients with Advanced Heart Failure16
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis15
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia15
SGLT2 Inhibitors and Safety in Older Patients15
Clinical Practice Guidelines in Cardio-Oncology15
Spontaneous Coronary Artery Dissection14
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction14
Congestion in Patients with Advanced Heart Failure14
Obesity and Heart Failure with Preserved Ejection Fraction13
Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction12
Cardiac Magnetic Resonance Quantification of Structure-Function Relationships in Heart Failure11
Biomarkers in Heart Failure11
Role of Cardiac Rehabilitation After Ventricular Assist Device Implantation11
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care10
Anemia and Management of Heart Failure Patients10
Pathophysiology of Advanced Heart Failure10
Cardiac Amyloidosis10
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis10
Mitral and Tricuspid Valves Percutaneous Repair in Patients with Advanced Heart Failure9
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies9
Role of Cardiac Magnetic Resonance Imaging in Heart Failure9
Using Artificial Intelligence to Better Predict and Develop Biomarkers9
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction9
Genetics in Congenital Heart Diseases9
Hypertension and Heart Failure with Preserved Ejection Fraction9
Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology8
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity8
The Role of Cardiovascular MRI in Cardio-Oncology8
Myocarditis Following COVID-19 Vaccination7
Advanced Heart Failure in Special Population—Pediatric Age7
SGLT2 Inhibitors in Heart Failure7
Cardiovascular Magnetic Resonance of Myocardial Fibrosis, Edema, and Infiltrates in Heart Failure7
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care7
Machine Learning in Cardiovascular Imaging7
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging6
Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure6
Renoprotective Effects of SGLT2 Inhibitors6
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk6
Cardiac Resynchronization Therapy in Patients with Heart Failure6
A Review of Heart Failure in Patients with COVID-196
Valvular Disease and Heart Failure with Preserved Ejection Fraction6
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome6
SGLT2 Inhibitors and Peripheral Vascular Events6
Advanced Heart Failure in Special Population6
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction5
Stage A Heart Failure5
Magnetic Resonance-Based Characterization of Myocardial Architecture5
Right Heart Catheterization in Patients with Advanced Heart Failure5
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension5
Cardiovascular Health Care Implications of the COVID-19 pandemic5
Assessment of Pericardial Disease with Cardiovascular MRI5
The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy5
T-cell Immunotherapy and Cardiovascular Disease5
Genetics of High-Altitude Pulmonary Edema5
Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI5
Sleep Disorder and Heart Failure with Preserved Ejection Fraction5
SGLT2 Inhibitors in Type 2 Diabetes Mellitus5
Impact of COVID-19 on Acute Myocardial Infarction Care5
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis4
Noncoding RNAs in Pulmonary Arterial Hypertension4
Artificial Intelligence and Mechanical Circulatory Support4
Measuring Myocardial Energetics with Cardiovascular Magnetic Resonance Spectroscopy4
Therapy-Related Clonal Hematopoiesis4
Struggling Between Liver Transplantation and Portopulmonary Hypertension4
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension4
Oxygen Therapy in Pulmonary Vascular Disease4
Use and Prognostic Implications of Cardiac Troponin in COVID-194
Heart Failure Preserved Ejection Fraction in Women4
Cardiovascular Magnetic Resonance in Right Heart and Pulmonary Circulation Disorders4
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support4
Framework for Digital Health Phenotypes in Heart Failure4
Telehealth in Heart Failure4
Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction4
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction4
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction4
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management4
Heart Failure with Preserved Ejection Fraction: Current Opinion and Future Perspectives3
Cardiovascular Magnetic Resonance in Heritable Cardiomyopathies3
Stress Testing in Heart Failure with Preserved Ejection Fraction3
Noninvasive Assessment of Ventricular-Arterial Coupling in Heart Failure3
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors3
Listing Criteria for Heart Transplant3
Cardiovascular Magnetic Resonance in Congenital Heart Disease3
Invasive Hemodynamics in Heart Failure with Preserved Ejection Fraction3
Role of New Technologies in Supporting the Treatment of Complex Patients3
Digital Transformation in Medicine to Enhance Quality of Life, Longevity, and Health Equity3
The Cardiovascular Manifestations of COVID-193
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy2
When to Use Cardiovascular Magnetic Resonance in Patients with Heart Failure2
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice2
Primary Mitral Regurgitation and Heart Failure2
Challenges in Pulmonary Hypertension2
Radiation-Induced Cardiac Dysfunction2
Disease-modifier Drugs in Patients with Advanced Heart Failure2
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-192
Cardiovascular Imaging in Cardio-Oncology2
Advanced Heart Failure in a Special Population2
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure2
Electronic Health Records and Heart Failure2
Sex- and Gender-Related Aspects in Pulmonary Hypertension2
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events2
Application of 3D Printing Technology in Heart Failure2
Arrythmia-Mediated Valvular Heart Disease2
Arrhythmic Complications Associated with Cancer Therapies2
Novelties in Therapy of Chronic Heart Failure2
Tricuspid Regurgitation and Right Heart Failure2
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology1
Mechanical Circulatory Support in COVID-191
Asymptomatic Left Ventricular Dysfunction1
Interatrial Shunt Devices1
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure1
Cardioprotection of High-Risk Individuals1
Cardiovascular Magnetic Resonance in Valvular Heart Disease–Related Heart Failure1
Pregnancy and Pulmonary Hypertension1
Understanding Myocardial Metabolism in the Context of Cardio-Oncology1
Training and Career Development in Cardio-Oncology Translational and Implementation Science1
Adults with Congenital Heart Disease and Transplant1
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension1
Arrhythmogenic Cardiomyopathy1
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes1
Role of Cardiovascular Magnetic Resonance in Ischemic Cardiomyopathy1
Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease1
Myocardial Dysfunction in Patients with Cancer1
The Emerging Role of Artificial Intelligence in Valvular Heart Disease1
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease1
Targeted Therapies for Microvascular Disease1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?1
Clinical and Molecular Aspects of Naxos Disease1
Copyright1
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All1
Novel Approaches to Sleep Apnea in Heart Failure1
Heart Failure Clinics1
Amyloidosis and Amyloidogenesis1
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine1
Remote Monitoring Devices and Heart Failure1
Surgical Considerations in Adult Congenital Heart Disease Heart Failure1
Cardiac Amyloidosis0
Forthcoming Issues0
Advanced Heart Failure: From Pathophysiology to Clinical Management0
Contributors0
When all Else Fails, Try This0
Aortic Valvular Stenosis and Heart Failure0
Copyright0
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure0
Copyright0
Genotype-Phenotype Correlations in ATTR Amyloidosis0
Copyright0
Contributors0
Contents0
Forthcoming Issues0
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure0
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction0
Contents0
The War Against Heart Failure Hospitalizations0
Pathophysiology of Cardiac Amyloidosis0
Changing Landscape of Heart Failure Imaging0
Contributors0
The Arrhythmic Phenotype in Cardiomyopathy0
Tafamidis in the Treatment of ATTR-related Cardiomyopathy0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis0
Management of Advanced Heart Failure: The Science of Uncertainty and the Art of Probability0
Standard Therapy in Cardiac Amyloidosis0
Copyright0
The Pathophysiology(ies) of Heart Failure in Adults with Congenital Heart Disease0
Latest Updates in Heart Failure Imaging0
Mitral Regurgitation0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease0
Covid-190
Contributors0
Contributors0
Contributors0
Contributors0
Challenges in Pulmonary Hypertension0
Contents0
Copyright0
Interventional Approaches to Augment Pharmacotherapy in Heart Failure0
Contributors0
Contents0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis0
Forthcoming Issues0
Contents0
Cardiovascular Magnetic Resonance0
Copyright0
Contributors0
Copyright0
Obesity in Heart Failure with Reduced Ejection Fraction0
Copyright0
Clinical Use of Biomarkers in Cardiac Amyloidosis0
Forthcoming Issues0
Forthcoming Issues0
Valvular Heart Failure due to Tricuspid Regurgitation0
Cardiovascular Effects of COVID-190
Forthcoming Issues0
Contributors0
Heart Failure with Preserved Ejection Fraction0
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis0
Forthcoming Issues0
Copyright0
Contributors0
Contents0
Translational Research in Cardio-Oncology0
Contributors0
Unusual Forms of Pulmonary Hypertension0
Contents0
Cardiac Amyloidosis0
Contributors0
SGLT2 Inhibitors Are Lifesavers in Heart Failure0
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging0
Copyright0
Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis0
Contents0
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now0
Digital Health0
Clinical Heart Failure Scenarios: From Prevention to Overt Disease and Rehabilitation0
Multimodality Imaging in Aortic Stenosis0
Preload Reduction Therapies in Heart Failure0
Forthcoming Issues0
Intracardiac and Vascular Hemodynamics with Cardiovascular Magnetic Resonance in Heart Failure0
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?0
Contributors0
Valvular Heart Disease and Heart Failure0
Contributors0
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies0
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension0
Copyright0
Specific Therapy in Transthyretin Amyloid Cardiomyopathy0
Novel Non-pharmacological Approaches to Heart Failure0
SGLT-2 Inhibitors0
Emerging Roles for Artificial Intelligence in Heart Failure Imaging0
Arrhythmias in Adult Congenital Heart Disease Heart Failure0
Extracardiac Prothrombotic Effects of COVID-190
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease0
Contents0
0.064706087112427